TG Therapeutics Announces Schedule of Data Presentations for

NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data from the ULTIMATE I & II Phase 3

Related Keywords

Colorado , United States , United Kingdom , West Palm Beach , Florida , Lawrence Steinman , Enrique Alvarez , National Multiple Sclerosis Society , Tg Therapeutics Inc , Research In Multiple Sclerosis , Cms Center , Drug Administration , European Commission , Zimmermann Professor Of Neurology Neurological Sciences , Missouri Baptist Medical Center , Pediatrics At Stanford University , University Of Colorado , Linkedin , Sclerosis International Federation , Healthcare Products Regulatory Agency , Globe Newswire Tg Therapeutics Inc , Exchange Commission , Americas Committee For Treatment , Nasdaq , Americas Committee , Multiple Sclerosis , Presentation Title , Pseudoexacerbation Paradox , High Efficacy Therapy , Poster Session , Poster Number , Barry Singer , Baptist Medical Center , Expanded Disability Status Scale , Zimmermann Professor , Neurological Sciences , Hepatitisb Virus , Multifocal Leukoencephalopathy , Infants Born , Common Adverse Reactions , Formerly Twitter , Private Securities Litigation Reform Act , Annual Report , Accessed October , Multiple Sclerosis International Federation , Region ,